Journal of Dermato-Oncology

I envision a future where our journal serves as a platform for sharing innovations and initiating and propagating collaborations among the cutaneous oncology community.

Our journal will not only disseminate innovative research; it will also catalyze progress, inspire curiosity, and foster a strong sense of purpose among researchers, scholars, and clinicians.

My vision encompasses the following objectives of the Journal of Dermato-Oncology.

Advancing Knowledge: The primary mission of our journal is to be at the forefront of knowledge dissemination. Our journal will focus on consistently publishing groundbreaking and paradigm-shifting discoveries.

Global Collaboration: Our journal will foster a global network of scholars, scientists, and researchers and will serve as a platform for international collaboration, welcoming submissions and perspectives from all corners of the world.

Interdisciplinary Excellence: I believe that the most transformative breakthroughs occur at the intersection of disciplines. We will actively encourage and celebrate interdisciplinary research, nurturing an environment of collaborations to understand complex problems, make novel discoveries, and create innovative solutions.

Ethical Research: Our journal will rigorously uphold ethical research practices, ensuring transparency, integrity, and responsibility in every study we publish.

Open Access and Accessibility: We will work towards making our journal more accessible through open access initiatives, affordable publication fees, and language translations. Our goal is to break down barriers to knowledge sharing.

Quality Peer Review: We will maintain a stringent peer review process that ensures the highest quality of published work. The peer review process will be fair, constructive, and timely, providing authors with valuable feedback to improve their research.

Overall, my vision as Editor-in-Chief is to lead our journal to become a global hub of knowledge creation, collaboration, and dissemination, guided by the principles of excellence, integrity, inclusivity, and accessibility.

Taylor & Francis are currently supporting a 100% APC discount for all authors until the end of 2024, plus VAT or other local taxes where applicable in your country. There is no submission charge.

Nihal Ahmad is a Professor and Vice Chair for Research in the Department of Dermatology at the University of Wisconsin-Madison. He is also the Dr. Frederic E. Mohs Skin Cancer Research Endowed Chair and serves as a co-leader of the Cancer Prevention and Control program of the University of Wisconsin Carbone Cancer Center.

Dr. Ahmad also has a joint appointment as a Senior Research Career Scientist at the William S. Middleton Memorial Veterans’ Hospital (Madison, WI). Dr. Ahmad’s research focuses on two major lines of investigation: (1) the mechanism of cancer development, with a specific focus on cell cycle and cell signaling; and (2) the prevention and experimental therapeutics of cancer by naturally occurring agents. He has considerable expertise in cancer biology and cancer prevention and therapeutics, especially focusing on skin and prostate cancers. Dr. Ahmad also studies the mechanisms associated with cutaneous ultraviolet (UV) responses. His research is funded by the National Institutes of Health and the Department of Veterans Affairs. He has published more than 220 papers in a wide range of high-impact scientific journals, in addition to a number of book chapters and scientific abstracts.

He is an Associate Editor of Photochemistry and Photobiology, Toxicology and Applied Pharmacology, Frontiers in Oncology, and Journal of Skin Cancer. He also serves on the editorial board of several journals.